Literature DB >> 19786672

Weighing the benefits and downsides of prostate-specific antigen screening.

Michael Pignone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19786672     DOI： 10.1001/archinternmed.2009.269

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  4 in total

1.  National evidence on the use of shared decision making in prostate-specific antigen screening.

Authors:  Paul K J Han; Sarah Kobrin; Nancy Breen; Djenaba A Joseph; Jun Li; Dominick L Frosch; Carrie N Klabunde
Journal:  Ann Fam Med       Date:  2013 Jul-Aug       Impact factor: 5.166

2.  Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial.

Authors:  Kathryn L Taylor; Randi M Williams; Kimberly Davis; George Luta; Sofiya Penek; Samantha Barry; Scott Kelly; Catherine Tomko; Marc Schwartz; Alexander H Krist; Steven H Woolf; Mary B Fishman; Carmella Cole; Edward Miller
Journal:  JAMA Intern Med       Date:  2013-10-14       Impact factor: 21.873

3.  Discussing uncertainty and risk in primary care: recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening.

Authors:  Michael Wilkes; Malathi Srinivasan; Galen Cole; Richard Tardif; Lisa C Richardson; Marcus Plescia
Journal:  J Gen Intern Med       Date:  2013-05-07       Impact factor: 5.128

4.  PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study.

Authors:  Blanca Lumbreras; Lucy Anne Parker; Pablo Alonso-Coello; Javier Mira-Bernabeu; Luis Gómez-Pérez; Juan Pablo Caballero-Romeu; Salvador Pertusa-Martínez; Ana Cebrián-Cuenca; Irene Moral-Peláez; Maite López-Garrigós; Carlos Canelo-Aybar; Elena Ronda; Mercedes Guilabert; Antonio Prieto-González; Ildefonso Hernández-Aguado
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.